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Abstract  
Background. Fetal aortic valvuloplasty (FV) aims to prevent fetal aortic valve stenosis 
progressing into hypoplastic left heart syndrome (HLHS) resulting in a postnatal 
univentricular (UV) circulation. Despite increasing numbers of FVs performed worldwide, the 
natural history of the disease in fetal life remains poorly defined.  
The primary aim of this study was to describe the natural history of fetal aortic stenosis and, 
secondarily, to test previously published criteria designed to identify cases of evolving HLHS 
with the potential for a biventricular (BV) outcome following FV. 
Methods. We report the natural history of 107 fetuses in continuing pregnancies that did not 
undergo FV from a retrospective multicenter study in Europe of 214 fetuses with aortic 
stenosis (2005-2012). We examined longitudinal changes in Z-scores of aortic and mitral 
valve and left ventricular dimensions, and documented direction of flow across foramen 
ovale and aortic arch, and mitral valve inflow pattern and any changes to determine those 
fetuses satisfying the Boston criteria for emerging HLHS and to estimate the proportion of 
these that would also have been considered ideal FV candidates. We applied the threshold 
score where a score of 1 was awarded to fetuses for each Z-score meeting the following: left 
ventricular length and width > 0; mitral valve width > -2 and aortic valve width > -3.5 and also 
where the pressure gradient across either the mitral or aortic valve was > 20 mmHg and 
compared the predicted circulation with known survival and final postnatal circulation (BV; 
UV or conversion from BV to UV). 
Results. In the 107 ongoing pregnancies there were 8 spontaneous fetal deaths, 
resulting in 99 live-born children.  5 were lost during follow up, 5 had comfort care and 
4 had mild aortic stenosis not requiring intervention. There was an intention to treat in 
the remaining 85 but 5 of them died before surgery before the circulation could be 
determined. Thus 80 underwent postnatal procedures with 44 BV, 29 UV and 7 BV-UV 
outcomes. 
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70/85 children (82%) with an intention to treat had ≥30 day survival. Survival was superior 
in BV circulation at median 6 years (p=0.041).  
Aortic valve size was significantly smaller at presentation in fetuses with UV outcomes 
(p=0.004) but its growth velocity was similar in both circulatory outcomes. In contrast the 
mitral valve (p=0.008) and left ventricular inlet length (p=0.0042) and width (p= 0.0017) were 
significantly reduced by term in fetuses with UV compared to BV outcomes. 
Fetal data from 70 treated neonates, recorded before 30 completed gestational weeks was 
evaluated for emerging HLHS. Forty-four had moderate or severe left ventricular depression 
and 38 of these had retrograde flow in the aortic arch with a further two having left to right 
flow at atrial level and a–wave reversal in the pulmonary veins. Thus 40 of the 70 satisfied 
the criteria associated with emerging HLHS and a BV circulation was documented in 13, 
(33%). Twelve of the 40 fetuses (30%) had a threshold score of 4 or 5, with a BV circulation 
in 5 (42%) of them without fetal intervention. 
Conclusions. Our natural history cohort of children diagnosed with aortic stenosis with known 
outcomes shows that a substantial proportion of fetuses meeting the criteria for emerging 
HLHS, with or without favorable selection criteria for FV, had a sustained BV circulation 
without fetal intervention. This indicates that further work is needed to refine selection criteria 
to offer appropriate therapy to fetuses with aortic stenosis. 
 
Key words: fetal heart; aortic valve stenosis; valvuloplasty, natural history 
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Introduction 
Prenatal diagnosis of aortic stenosis is relatively rare, occurring in less than 10% of 
newborns requiring neonatal intervention1. Fetal aortic valvuloplasty (FV) is offered in the 
setting of significant aortic stenosis with the intent to alter fetal left heart hemodynamics that 
might result in a univentricular (UV) circulation after birth. However the procedure is not 
without risk and experienced centers report a 10% procedure related loss 2,3 with higher 
losses reported by multicenter registries with more varied experience. 4  
There are important challenges in conducting a randomized trial to assess risks and benefits 
of FV in this rare condition and natural history reports are limited by their size, quality of 
prenatal data and postnatal follow up.5-7  Knowledge of the natural history of fetal aortic 
stenosis is important for health professionals providing fetal counseling. 
The primary aim of this study was to report the spectrum of fetal left heart morphology and 
physiology, pregnancy outcomes, survival and final circulatory pathways in a natural history 
cohort of aortic stenosis established by the Fetal Working Group of the Association for 
European Paediatric Cardiology.  A secondary aim was to test previously published selection 
criteria for emerging hypoplastic left heart syndrome (HLHS) and ideal candidates for FV on 
this population of fetuses by comparing predicted with observed outcomes. 6,2 
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Methods 
We present the natural history of 107 fetuses with aortic stenosis not undergoing FV from 23 
centres in 12 European countries who provided retrospective information from January 2005 
to May 2012. The multicenter multinational study of fetal aortic stenosis was established by 
the Fetal Working Group of the Association for European Paediatric Cardiology and enrolled 
214 fetuses with a spectrum of aortic valve disease, 67 of whom underwent FV and are not 
reported here. (Figure 1). 
Cases suitable for inclusion in the study had usual atrial arrangements, concordant atrio-
ventricular and ventriculo-arterial connections with stenosed but still patent aortic valves. 
Associated findings of mitral valve hypoplasia, left ventricular fibroelastosis, coarctation and 
persistent left superior vena cava were accepted. The morphological and physiological 
data were collected prospectively and measured by the fetal cardiologists of the participating 
centres and recorded on a standardized data collection form.  
In order to facilitate data acquisition, the core investigators (AK and AO) offered to visit sites.  
In practice, most contributors sent completed data sheets to the core investigators, and 35% 
were visited by one co-author (AK) who retrieved and documented recorded measurements 
and added any missing measurements from available clips.  
We documented right and left sided atrioventricular valve lateral diameters and ventricular 
sizes, Doppler velocities and waveform patterns through pulmonary veins, the ductus 
venosus, foramen ovale and through both semilunar valves and about the aortic and ductal 
arches. The demographic data of the pregnancies and fetuses and follow-up data was 
collated by AK and AO who also calculated the Z-scores of the cardiac measurements 
based on gestational age.8 
The analysis of circulatory outcomes was confined only to children who underwent (or 
intended) a postnatal surgical or catheter procedure during the neonatal period. None had 
multiple congenital abnormalities or abnormal karyotype and no maternal conditions or 
multiple pregnancies resulted in exclusion from the analysis. In ongoing pregnancies, Z-
scores of aortic and mitral valves and left ventricular length and width, and any change in 
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physiological parameters recorded during the pregnancy were compared at first and last 
echo. We recorded mitral valve flow profile (biphasic, monophasic or absent), direction of 
flow in the aortic arch (forward or reversed including bidirectional) and across the atrial 
septum (right to left, left to right, restrictive or none) and the peak pressure gradient 
generated across the aortic and mitral valves. These variables were analyzed in relation to 
survival and circulatory outcome in the 80 liveborn children where postnatal therapy was 
performed (supplementary tables 3 and 4). 
 
The postnatal surgical pathway was considered biventricular (BV) if the first procedure was 
balloon aortic valvuloplasty or surgical valvotomy, or if a Ross or Ross-Konno was 
performed. The fetus followed a primary UV circulatory pathway when a primary Norwood or 
Hybrid procedure was performed and a BV-UV conversion defined if a BV procedure was 
followed by a Norwood or Hybrid procedure at any age. No children were transplanted and 
no UV circulation was later converted to BV using left ventricular rehabilitation strategies. 
 
Previously published natural history experience from Boston in 2006 6 describes fetuses with 
aortic stenosis likely to develop HLHS during pregnancy. In order to derive the proportion of 
our natural history cohort expected to progress to HLHS using the Boston 2006 criteria, we 
took physiological data from the first fetal echocardiogram before 30 completed gestational 
weeks and combined this with the LV inlet length (major axis) Z-scores (Figure 2).  
We then included peak pressure gradients derived from mitral regurgitation jets and Doppler 
flow velocities across the aortic valve and applied the Boston 2009 threshold score to those 
previously selected as likely to develop HLHS according to Boston 2006. A threshold score 
of 4 or 5 defined the morphological dimensions and physiology necessary to permit a BV 
circulatory outcome following technically successful FV – thus defining the “ideal FV 
candidate”. A score of 1 was awarded to fetuses for each Z-score meeting the following: left 
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ventricular length and width > 0; mitral valve width > -2 and aortic valve width > -3.5 and also 
where the pressure gradient across either the mitral or aortic valve was > 20 mmHg.2  
This enabled us to describe the proportion of natural history fetuses with emerging HLHS 
who also fulfilled the criteria for ideal FV candidates, yet remained BV without fetal therapy. 
The Ethics Committee at Imperial College, London, considered the study audit of practice 
and no specific ethical approval was required. Data from the postnatal pre-intervention 
echocardiogram have been used in a blinded study of postnatal surgical decision-making in 
71 of this natural history cohort reported previously 9. 
 
Data analysis 
Summary statistics of the natural history fetal cohort are presented. Logistic regression 
assessed Z-score change during the pregnancy and its effect on postnatal circulation. 
The categorical physiological data were dichotomized to code for whether individual 
parameters changed during pregnancy and Fisher’s exact test was used to compare 
the effect on postnatal circulation. Mann-Whitney–U test was used to analyze the 
continuous variables of gestation and left ventricular morphology by circulatory 
outcome. Regression analysis calculated the OR of overall survival (with any 
circulation) in those meeting the fetal criteria for emerging HLHS compared with those 
not meeting them. The effect of first and final circulation on survival were assessed 
using Kaplan Meier survival curves. Statistical significance was determined at p<0.05. 
Statistical analysis was performed with Stata version 13, StataCorp, College Station, 
Texas. 
 
 
 
Results 
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Overview:  Figure 1 summarizes outcomes of the 147 fetuses not undergoing FV from the 
whole cohort of 214 enrolled fetuses. The mean (SD) gestational age of these 147 fetuses at 
the first fetal echocardiogram, with adequate data submitted to the study, was 23.5 (5) 
weeks.  
Termination of pregnancy occurred in 40 (27.2%). Pregnancies ending in termination in the 
whole cohort of 214 fetuses were not more severely affected than on-going pregnancies, but 
were younger. (Supplementary Table 1)  
Circulation and survival outcomes in ongoing pregnancies:  In the 107 ongoing natural 
history pregnancies there were 8 spontaneous fetal deaths (7,5%), resulting in 99 live-
born children.   
No postnatal aortic valve interventions were performed on 14 of the 99 liveborns. Four never 
required intervention on the aortic valve during the study period and were excluded: three 
with mild aortic valve stenosis after birth and the fourth with a primary lesion of coarctation 
with moderate aortic stenosis (30 mmHg peak gradient). A further 5 were lost during follow 
up and 5 received comfort care.  
Therefore, there was intention to treat in 85 newborns with severe aortic stenosis. None 
had abnormal chromosomes and one was from a twin pregnancy. However, 5 died before 
surgery, including two born preterm (25 weeks and 30 weeks) the latter after attempts to 
open a closed atrial septum, and the circulation could not be determined.  Ultimately, 80 
neonates underwent postnatal procedures with 44 BV, 29 UV and 7 BV-UV circulatory 
outcomes (Figure 1). Thirty day survival was 82% (70/85) and survival at median 6 years 
was superior in BV circulation (p=0.041).  
Hydrops:  Twelve of 147 fetuses were hydropic. Their age at presentation and 
pathophysiology are in Supplementary Table 2. Three suffered spontaneous fetal demise 
and one pregnancy with intact atrial septum was terminated. Of the eight liveborns, six died: 
one following attempted balloon aortic valvuloplasty; one after Rashkind and Norwood, two 
had comfort care and two died before any procedure could be performed.  Only two survived 
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(one was delivered at 33 weeks), both developed restrictive atrial septum, had antegrade 
fetal arch flow, and only required balloon aortic valvuloplasty after birth. They are alive with a 
BV circulation at 9.1 and 6.6 years, respectively. 
Changes in Morphology and physiology during pregnancy in relation to outcome:   
Table 1 compares fetal Z-scores by postnatal circulation in 51 liveborns with data available 
before 30 gestational weeks, who survived for more than 3 months. Children with a BV 
circulation had better initial fetal Z-scores than those with a final UV, but the only significant 
variable was mitral valve diameter (p=0.004).  
In addition, supplementary Tables 3 and 4 show the Z-scores at first scan with sufficient 
data, separated by eventual circulation for all 80 children receiving treatment and also 
separated by time of demise in those dying before 3 months. Logistic regression of the 85 
liveborns, treated or with intention to treat, demonstrated a four-fold increased risk of dying 
in children classified as evolving HLHS 6 (OR 3.98, 95%CI 1.56 to 10.14, p=0.0028).  
Figure 3 shows the gestational changes in left-sided morphology for 69 fetuses with at least 
two examinations with the regression analysis in Table 2. The mean (SD) gestational age at 
first scan was 24.3 (±4.2) and at the last scan 32.9 (±3.0) weeks. The median (range) of Z-
scores at first echo was: mitral valve width -2.0 (-9.3 to +4.0); aortic valve width -1.6 (-6.7 to 
+2.3); left ventricular inlet length -1.2 (-5.8 to +4.6) and left ventricular width +0.2 (-5.8 to 
6.5). Those with postnatal UV circulation showed a significant decrease in growth velocity of 
the mitral valve (p=0.008), left ventricular inlet (p=0.004) and width (p=0.002), compared to 
those with postnatal BV circulation.  However there was no difference in the growth velocity 
of the aortic valve diameter Z-scores (p=0.229) between the different eventual circulations 
(Table 2).  
Thirteen fetuses had an alteration of physiology during the second and third trimesters: two 
showed new left to right flow across the foramen ovale, one of whom also had new reversal 
of aortic arch flow, while one fetus showed normalization of foramen flow. Six fetuses 
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showed deterioration of mitral valve flow; three developing atresia and three short, 
monophasic mitral valve inflow, one of whom also showed new reversed flow in the 
transverse aortic arch.  A further three fetuses showed new retrograde arch flow and one 
normalized during pregnancy. Although not statistically significant, five of the six fetuses 
whose mitral valve became atretic or monophasic in pregnancy had a UV circulation after 
birth (p=0.069) while the development of new retrograde arch flow alone was equally likely to 
result in a BV (3) or UV (3) circulation (p=1.00).  
Published selection criteria:  Figure 2 shows 13 of the 40 (33%), who satisfied the criteria for 
emerging HLHS, 6 had a BV circulation, with 9 alive at a median of 6.9 (4.2 to 8.9) years. 
Table 3 shows the proportion of these 40 emerging HLHS fetuses who would have also 
been considered ideal FV candidates using the threshold score 2. Twelve of the 40 fetuses 
(30%) had a threshold score of 4 or 5, thus satisfying the criteria. Five of the 12 (42%) had a 
BV circulation without fetal intervention.  
Postnatal management and survival analysis:  Postnatal management was decided by the 
local teams and 51 were assigned an initial BV pathway, 7 requiring subsequent conversion 
to UV, and 29 followed an initial UV pathway. There were 11 early hospital deaths (13.8% 30 
day-mortality) after surgery or interventional catheter; 7 following Norwood stage 1 (one after 
Rashkind); two after aortic valvuloplasty (1 a 31 week premature baby and 1 with a giant 
right atrium with bronchial compression after lobectomy). Another baby died from 
septicaemia aged 13 days after aortic valvuloplasty followed by stenting of the isthmus and 
duct, and one baby died at 30 days following Ross procedure for severe aortic regurgitation 
and LV dysfunction. Three of these had an intact atrial septum at delivery. Of all 85 babies 
considered for treatment after birth, (Figure 1) fifteen died in the first 30 days (17.6% 
mortality). The median follow-up of the remaining 69 was 6 years (range 46 days to 9.4 
years). Survival from birth for those undergoing an initial BV route (balloon aortic 
valvuloplasty or surgery) was compared with those originally designated UV using Kaplan 
Meier analysis, (Figure 4). In this analysis the 7 BV to UV conversions were treated as an 
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event, removing them from the BV cohort at the time of conversion. (Figure 4a) Hazard 
analysis showed no significant difference in survival between the groups, 73.7% vs 54.5%, 
p=0.058. If these seven children who changed circulatory designation are not included in the 
Kaplan Meier analysis, those with a sustained BV circulation show a small but significant 
survival advantage over those with UV circulation, 76.1% vs 54.5%, p=0.041. (Figure 4b) 
The deaths were clustered in the first two years with no further demises out to almost 10 
years.  
Supplementary table 5 lists the number and type of interventions of the 80 children 
undergoing postnatal interventions. There were a total of 200 catheter and surgical 
procedures: the 29 children following an initial UV pathway from birth had 67 procedures, 
with 9 dying after stage 1 and 3 after the Glenn (62% survival). The 44 children with a 
sustained BV circulation had 92 procedures and 8 deaths (82% survival). Seven children 
required conversion from BV to UV and had 41 procedures between them and two died. 
They were converted at median age of 27 (8 to 286) days to a UV circulation and 3 of them 
had hybrid procedures which accounted for the majority of the interventions. Two children 
died (2 months and 1.7 years) following the hybrid pathway, one after 12 procedures, and 
the remaining five are alive out to almost 10 years, one child having had 10 procedures. The 
first procedure in the 51 children following an initial BV pathway was balloon aortic 
valvuloplasty in 48 and surgical valvotomy in 3. Repeat balloon valvuloplasty was required in 
2 children, associated with aortic arch repair in 2 or arch stenting in one. Nine had a surgical 
valvotomy, three as their initial procedure. Seven children had mitral valve surgery (included 
under “complex” and Ross in Figure 1), one had two surgeries for mitral valve perforation, 
three had additional Ross-Konno procedures and one a Ross. Another child had 6 
procedures including arch stenting and dilation and another with Shone complex had four 
surgeries requiring coarctation repair and resection of sub-aortic membranes as well as 
supra-mitral valve surgery. Seven children overall had Ross procedures, one with sub-aortic 
shelf resection and another had homograft replacement and five underwent the Ross-Konno 
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procedure. Two children were reported to have pulmonary hypertension; one with a giant left 
atrium compressing the bronchi died in the neonatal period after lobectomy and the other is 
alive at 7.5 years on no medical or long-term oxygen therapy. Function is reported to be 
good in the surviving cohort with most in New York Heart Association (NYHA) Functional 
Classification 1. 
 
Discussion 
Our study presents natural history outcomes of 107 fetuses with aortic stenosis collected in 
the current era (2005 -2012). This is a large natural history series, particularly as fewer than 
10% of neonates with critical aortic stenosis are reported to have had a prenatal diagnosis.1 
The strength of this cohort is that it documents outcomes of fetuses with serial fetal 
morphology and physiology followed out to over 9 years, (median 6 years), and thus 
provides health professionals and parents with information on both the spectrum of the 
disease as well as prognosis in relation to circulatory outcomes. 
When we applied the threshold score2 to the 40 fetuses characterized as having emerging 
HLHS, 12 scored ≥4 and could be considered ideal FV candidates, yet a BV outcome was 
achieved in 5 (42%) of them without fetal therapy. Moreover 29% (8/28) of the remaining 
fetuses who would not have been chosen for fetal therapy because of a low threshold score 
also had a BV outcome. We cannot know if FV would have improved outcome further in this 
cohort, but the proportion of BV outcomes in those considered to be emerging HLHS 6 is at 
least equal to that achieved following fetal valvuloplasty2-4. We believe our data imply the 
threshold score2 may not be specific or sensitive enough in its selection of cases for 
valvuloplasty when applied to different populations.  
Previous natural history studies conclude that retrograde aortic arch flow is an important 
predictor of evolving HLHS 6,7. However we observed it in one third of our cohort satisfying 
the Boston 2006 criteria for emerging HLHS who had a postnatal BV circulation. Retrograde 
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aortic arch flow is described in aortic coarctation with biventricular outcome10 and in normal 
fetal hearts near term,11. Therefore we interpret this physiological parameter cautiously.  
Those with UV circulation had smaller aortic valves than the BV cohort initially, but valvar 
growth velocities were similar, unlike the those of the mitral valve and left ventricle which 
were significantly reduced in those eventually UV. Our findings are in line with the 
observations of left heart growth following successful FV where no real improvement in 
ventricular growth during pregnancy could be observed, despite successful intervention 2,3. 
We also observed that development of mitral valve atresia or monophasic flow during 
pregnancy was associated with a UV circulation. This is in agreement with the selection 
criteria for FV in Linz where longer mitral valve inflow duration (corrected for cardiac cycle) 
was predictive of postnatal BV circulation3. 
Neonatal mortality in aortic stenosis remains high compared with other cardiac lesions in 
Europe 12. Our natural history cohort was not super-selected as no differences in severity 
were demonstrated between the ongoing pregnancies and those terminated. Further 
demises occurred: spontaneous fetal demise of 7.5%, pre-surgical neonatal demise of 6% 
and a 10% neonatal post-procedural demise. Thus the 30-day survival of a newborn, 
intending postnatal treatment was 70/85 (82%). This is higher than the survival to hospital 
discharge of 57.5% following FV from the IFCIR multicenter registry4. The proportion of early 
survivors is influenced by disease severity and between one half and two thirds of our 
neonates receiving postnatal therapy fulfilled the characteristics of evolving HLHS 6. This 
increased their risk of dying during the study period four-fold compared to those with better 
anatomy and physiology at first fetal scan.  
Our natural history data show important similarities with the outcomes of the first 100 FV 
performed in Boston over a similar time period13. Both show similar survival of the 
biventricular and HLHS cohorts with differences in survival becoming apparent when only 
cardiac deaths and conversions from UV to BV were included in the Boston analysis. While 
we demonstrated better BV survival when those requiring conversion from BV to UV 
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circulations were not included in the analysis. However the final outcome depends not only 
on prenatal appearances but also on postnatal decision-making and team ethos, including 
the skill to maintain a BV circulation 9,13-17. The choice of postnatal circulatory pathway 
depends on neonatal appearances, functional parameters and local preferences9 and our 
children with aortic stenosis required a median of three episodes of often complex surgery, 
in line with others, and some had multiple catheter intervention 3,13-17. In our cohort worse 
outcomes were identified in children undergoing multiple interventional catheter procedures, 
particularly towards a hybrid strategy (supplementary table 5). Hybrid procedures reported in 
the European Congenital Heart Surgeons Association (ECHSA) database have a 38% 30-
day mortality with survival to hospital discharge of only 42%12. This postnatal therapeutic 
choice may be one reason for poor survival in some registry reports4. 
One major strength of this study is the multicenter design which allowed us to collect a 
relatively large number of cases. However the multicenter retrospective nature comes with 
several important limitations when compared to the ideal prospective large single-center 
study. There was a lower degree of uniformity of data collection and although guidance was 
provided on how to perform all morphological measurements, we were not able to 
standardize and assess reproducibility of measurements as is possible in a core-lab. 
Moreover, postnatal management decision making and surgical performance could not be 
considered uniform between centers. Other limitations of this study are common to other 
retrospective studies with incomplete data and inability to answer some questions. For 
example we do not know the decision-making behind referral for prenatal valvuloplasty, or 
for termination of pregnancy which lie beyond the scope of this study. The cohort has small 
numbers out to 10 years which reduces the power to make firm conclusions but the event 
rate after 18 months was low. We might anticipate more events occurring in later 
adolescence in both cohorts. 
In conclusion, our large natural history cohort of children with known outcomes diagnosed 
with aortic stenosis prenatally shows a substantial proportion of fetuses meeting the criteria 
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for emerging HLHS and to be ideal candidates for FV had a sustained BV circulation without 
fetal intervention. This indicates that further work is needed to refine selection criteria to offer 
appropriate therapy to fetuses with aortic stenosis. 
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Table 1. Comparison of gestational age and left heart Z-scores for 51 liveborn fetuses with 
data at or before 30 gestational weeks by postnatal circulation, who survived for more than 3 
months. 
 BV (27)  UV (24)  p  
 median range median range  
GA 24.0 18.6-30.0 23.0 18.0-30.0 0.383 
AoV -0.76 -5.14 to 2.28 -1.20 -6.70 to 0.29 0.076 
MV -1.06 -7.77 to 0.87 -3.90 -8.70 to 1.39 0.004 
LV inlet -0.59 -4.70 to 2.41 -1.86 -4.47 to 4.60 0.167 
LV width -0.26 -2.66 to 4.81 0.64 -4.94 to 3.76 0.299 
 
AoV: aortic valve; BV: biventricular circulation; BV-UV: biventricular to univentricular 
conversion; GA: gestational age in weeks; LV: left ventricle; MV: mitral valve; UV: 
univentricular circulation. 
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Table 2. Regression analysis demonstrating gestational changes in left sided cardiac 
morphology Z-scores in children with postnatal univentricular pathway using those with 
biventricular outcome as the reference group. 
Z score number coefficient SE 95% CI p 
AoV 48 -0.80 0.65 -2.11 to +0.52 0.229 
MV 45 -2.25 0.80 -3.87 to -0.63 0.008 
LV inlet 54 -1.79 0.60 -2.99 to -0.59 0.004 
LV width 57 -1.77 0.54 -2.84 to -0.69 0.002 
 
AoV: aortic valve; LV: left ventricle; MV: mitral valve 
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Table 3. Boston 2009 threshold scores applied to 40 fetuses with aortic stenosis satisfying 
Boston 2006 criteria for emerging HLHS and their final circulatory outcomes. 
Threshold 
Score 
Cases 
n=40 
BV 
n=13 
UV 
n=27 
0 4 2 2 
1 6 1 5* 
2 10 2 8 
3 8 3 5* 
4 7 1 6** 
5 5 4 1 
 
* UV includes 1 BV-UV; ** UV includes 2 BV-UV; BV: biventricular circulation; BV-UV: 
biventricular to univentricular conversion; UV: univentricular circulation. 
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